Management of Venous Thromboembolism: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
Open Access
- 6 February 2007
- journal article
- practice guideline
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 146 (3) , 204-210
- https://doi.org/10.7326/0003-4819-146-3-200702060-00149
Abstract
Venous thromboembolism is a common condition affecting 7.1 persons per 10 000 person-years among community residents. Incidence rates for venous thromboembolism are higher in men and African Americans and increase substantially with age. It is critical to treat deep venous thrombosis at an early stage to avoid development of further complications, such as pulmonary embolism or recurrent deep venous thrombosis. The target audience for this guideline is all clinicians caring for patients who have been given a diagnosis of deep venous thrombosis or pulmonary embolism. The target patient population is patients receiving a diagnosis of pulmonary embolism or lower-extremity deep venous thrombosis. *Clinical Efficacy and Assessment Subcommittee of the American College of Physicians: Douglas K. Owens, MD, MS (Chair); Mark Aronson, MD; Donald E. Casey Jr., MD, MPH, MBA; J. Thomas Cross Jr., MD, MPH; Nancy C. Dolan, MD; Nick Fitterman, MD; E. Rodney Hornbake, MD; Paul Shekelle, MD, PhD; Katherine D. Sherif, MD; and Kevin Weiss, MD, MPH (Immediate Past Chair). Commission on Science of the American Academy of Family Physicians: Eric M. Wall, MD, MPH (Chair); Kevin A. Peterson, MD, MPH; James M. Gill, MD; Robert C. Marshall, MD, MPH; Jonathan E. Rodnick, MD; Kenneth G. Schellhase, MD, MPH; Steven W. Strode, MD, MEd, MPH; Kurtis S. Elward, MD, MPH; James W. Mold, MD, MPH; Jonathan L. Temte, MD, PhD; Frederick M. Chen, MD, MPH; Thomas F. Koinis, MD; Donya A. Powers, MD; Karl M. Kochendorfer, MD; Peter John Oppelt; Herbert F. Young, MD, MA; and Bellinda K. Schoof, MHA. Approved by the American College of Physicians Board of Regents in April 2006. Approved by the American Academy of Family Physicians Board of Directors on 28 March 2006.Keywords
This publication has 57 references indexed in Scilit:
- A Prediction Rule to Identify Low-Risk Patients With Pulmonary EmbolismArchives of internal medicine (1960), 2006
- Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight HeparinAnnals of Internal Medicine, 2003
- Outpatient treatment of deep venous thrombosis: A clinical care pathway managed by the emergency departmentAnnals of Emergency Medicine, 2001
- Comparison of Low-Molecular-Weight Heparin, Administered Primarily at Home, with Unfractionated Heparin, Administered in Hospital, and Subcutaneous Heparin, Administered at Home for Deep-Vein ThrombosisAngiology, 1999
- Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolismCurrent Opinion in Pulmonary Medicine, 1998
- Rationale for spacer use in childrenPediatric Pulmonology, 1997
- Dalteparin: A Low-Molecular-Weight HeparinAnnals of Pharmacotherapy, 1997
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996